Avobenzone vs Cysteamine

Avobenzone: Provides UVA coverage within tested sunscreen formulas. Cysteamine: Can reduce melasma pigmentation in tested topical formulas.

Research updated 2026-10-25
Four La Roche-Posay Anthelios sunscreens on white, SPF 60 and SPF 50, with cream swatchesFour cysteamine products: a Senté tube, an Omic+ cream and box, a 5% cysteamine serum dropper and a Cyspera bottle

Which one is right for you?

Choose Avobenzone if…

Choose a comfortable broad-spectrum sunscreen; avobenzone is one possible UVA filter.

  • You want a lightweight chemical sunscreen
  • UVA protection without white cast
  • Daily wear under makeup

Choose Cysteamine if…

Consider for diagnosed melasma when a suitable topical option is needed.

  • Diagnosed melasma
  • Hydroquinone isn’t suitable
  • You can follow short-contact wash-off
Often combined

Can you use both?

Daily sunscreen is essential when using cysteamine for pigment.

At a glance

● Avobenzone
● Cysteamine
Type
Organic UVA filter
Pigment-targeting active
What it does
Provides UVA coverage within tested sunscreen formulas.
Can reduce melasma pigmentation in tested topical formulas.
Best for
Sunburn; Melasma; Wrinkles and Fine Lines
Melasma
Studied concentrations
Choose by broad-spectrum SPF and water-resistance claims, rather than filter percentage alone.
5% cream in controlled melasma trials; contact instructions vary by product.
When to use
Each morning and before sun exposure.
On the schedule specified for the product or prescribed treatment.
Time to results
Protection with correct application; prevention continues over time
Usually assessed over 8–16 weeks
Irritation
Can sting the eyes or irritate some skin; stop for a persistent rash.
Odour, stinging and irritation may limit use; follow wash-off instructions.
Sensitive skin
Choose a simple formula and test a small area first. Individual tolerance matters more than an ingredient’s reputation for being gentle.
Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.
Available
Prescription or cosmetic status depends on the active, formula and country; check the label.
Prescription or cosmetic status depends on the active, formula and country; check the label.

What it helps

Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.

Evidence level
Avobenzone
Cysteamine
Strong evidenceMost established uses
Sunburn: 1. Sunburn Header — Light Skin; Lighter skin.

Sunburn

A tested broad-spectrum sunscreen protects against UV exposure; avobenzone supplies UVA coverage.
—
Moderate evidenceSome supportive research
Flat tan patches with soft irregular edges across the forehead and upper cheek of an adult with light skin, the surface completely smooth.

Melasma

Broad-spectrum sun protection supports pigment care; it does not clear melasma alone.
A relaxed forehead with faint shallow horizontal fine lines.

Wrinkles and Fine Lines

Regular sunscreen helps prevent further photoaging.
Flat tan patches with soft irregular edges across the forehead and upper cheek of an adult with light skin, the surface completely smooth.

Melasma

A placebo-controlled trial found reduced pigmentation with 5% cream.
Insufficient evidence
Sensitive Skin on light skin.

Sensitive Skin

The reviewed sources do not establish this ingredient as a treatment for this concern.
Inflamed acne on light skin. The spots sit in a patch of pink, and the ring of redness around each one is easy to see. A few have a yellow-white head, and the skin between them is dry and flaking.

Acne

The reviewed sources do not establish this ingredient as a treatment for this concern.
Sensitive Skin on light skin.

Sensitive Skin

The reviewed sources do not establish this ingredient as a treatment for this concern.
Flat light-brown residual marks on a fair cheek.

Post-Inflammatory Hyperpigmentation

The cited melasma trial does not establish fading of every type of dark mark.
The front of a forearm on fair skin. Two pale patches with sharp edges sit against lightly tanned skin, and the difference between the patch and the skin around it is subtle.

Vitiligo

The reviewed sources do not establish this ingredient as a treatment for this concern.
How it works

Avobenzone

Avobenzone mechanism diagram. Takes up UVA energy: Avobenzone helps reduce UVA reaching the skin. Needs a stable filter blend: Other filters provide complementary coverage.
Open full-size diagram
Diagram explanation and sources

Takes up UVA energy: Avobenzone helps reduce UVA reaching the skin. Needs a stable filter blend: Other filters provide complementary coverage.

Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.

Source 1 · Source 2 · Source 3 · Source 4

Cysteamine

Cysteamine mechanism diagram. Affects melanin formation: Cysteamine acts through several pigment pathways. May help melasma: The formula, contact time and tolerance matter.
Open full-size diagram
Diagram explanation and sources

Affects melanin formation: Cysteamine acts through several pigment pathways. May help melasma: The formula, contact time and tolerance matter.

Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.

Source 1

Using both in one routine

Built from where each one usually sits in a routine. Introduce one at a time.

Morning
Step 1
Cleanser
Step 2
Moisturizer
Step 3
AvobenzoneMorning
Night
Step 1
Cleanser
Step 2
CysteamineNight
Step 3
Moisturizer

Strengths and forms

Concentrations

Avobenzone is a UVA filter with a U.S. monograph maximum of 3%. Its performance depends on the full sunscreen formula, not the percentage alone.

3%

U.S. sunscreen ceiling

A permitted maximum. This number is not the product’s SPF or a stand-alone measure of UVA protection.

Choosing a strength: Choose a finished, tested broad-spectrum sunscreen rather than a target avobenzone percentage.

Higher strengths: More of one filter is not a substitute for tested UVA and UVB protection or correct application.

Formula matters: Avobenzone needs an appropriate stabilized formulation and complementary UVB protection. Do not add raw filters to skincare.

5% cysteamine cream is the main concentration studied for melasma. Contact time is product-specific; some studied formulas are short-contact treatments rather than overnight creams.

5%

Studied melasma cream

Controlled trials studied this strength. One short-contact trial used a specific cream; follow the current product’s instructions rather than copying a study schedule.

Choosing a strength: Choose a finished topical product with clear instructions for how long to leave it on and when to rinse.

Higher strengths: There is no established benefit from escalating beyond the studied strength. Burning, redness or a persistent rash are reasons to stop and reassess.

Formula matters: Stabilization, the base cream and exposure time affect tolerability. Different cysteamine formulations need not have identical instructions.

Forms
Chemical sunscreen · Spray · Stick
Cream

When you’ll see results

Approximate windows, not promises.

● Avobenzone
● Cysteamine
First few weeks

First few weeksProtection starts with correct application; it does not require a weeks-long course.

First few weeksAssess tolerance first; pigment change is usually slower.

4–8 weeks

4–8 weeksConsistency matters; this is prevention, not a spot-clearing treatment.

4–8 weeksSome studied regimens begin showing pigment improvement.

8–12 weeks

8–12 weeksContinue correct application and reapplication.

8–12 weeksA useful review point for benefit and irritation.

3–6 months

3–6 monthsMonitor tolerance and sun exposure; a changing spot needs assessment.

3–6 monthsMany melasma trials assess results over three to four months; recurrence is common.

6–12 months

6–12 monthsPhotoaging prevention is a long-term benefit, not a promise of wrinkle reversal.

6–12 monthsLong-term use depends on the active; follow a monitored plan rather than extending treatment automatically.

Safety and sensitive skin

Common reactions

Can sting the eyes or irritate some skin; stop for a persistent rash.

Odour, stinging and irritation may limit use; follow wash-off instructions.

When to stop

Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.

Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.

Sensitive or inflamed skin

Choose a simple formula and test a small area first. Individual tolerance matters more than an ingredient’s reputation for being gentle.

Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.

Important limits

Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.

Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.

Pregnancy

Sunscreen use is encouraged in pregnancy; avobenzone is generally considered acceptable. Mineral filters are an alternative if you prefer.

Data in pregnancy are limited; ask the clinician managing your pregnancy before using.

How it works

In the skin

On the skin. The finished product delivers avobenzone in a particular vehicle.

Entering skin. Below 500 Da, but sunscreen works in its surface film. Human studies show some absorption; size alone does not establish absorption, harm or protection.

Conversion. No activation step is established as necessary for its intended topical role.

Skin response. Absorbs UVA energy; stability and combination with UVB filters determine the finished product’s protection.

Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.

On the skin. The finished product delivers cysteamine in a particular vehicle.

Entering skin. Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.

Conversion. No activation step is established as necessary for its intended topical role.

Skin response. Acts on pigment-related pathways; the cream, contact time and tolerance influence its practical effect.

Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.

Getting in
Below 500 Da, but sunscreen works in its surface film. Human studies show some absorption; size alone does not establish absorption, harm or protection.
Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.
Molecule size
Avobenzone · 310 Da
Cysteamine · 77 Da
Smaller than 500 Da passes the outer skin more easily. Size isn’t an effectiveness score.
500 Da guideline

Common questions

Avobenzone:What should I choose avobenzone for?

Choose a comfortable broad-spectrum sunscreen; avobenzone is one possible UVA filter.

Avobenzone:How strong is the evidence?

A randomized trial supports regular sunscreen use for photoaging prevention, not avobenzone alone. An FDA absorption study measured systemic exposure under study conditions; absorption alone did not establish harm.

Cysteamine:What should I choose cysteamine for?

Consider for diagnosed melasma when a suitable topical option is needed.

Cysteamine:How strong is the evidence?

A small placebo-controlled study supports 5% cream over four months. Active-comparator studies are small and do not prove equal efficacy to hydroquinone. The mass shown refers to the free base, not its hydrochloride salt.

Sources

Sources and further reading

  1. Sunscreen and prevention of skin aging: a randomized trial. (2013)
  2. Effect of Sunscreen Application on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial. (2020)
  3. Near-visible light and UV photoprotection in the treatment of melasma: a double-blind randomized trial. (2014)
  4. FDA sunscreen application guidance
  5. Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: a randomized double-blind placebo-controlled trial. (2015)
  6. FDA sunscreen monograph M020: permitted concentrations
  7. FDA sunscreen regulatory updates, including 2026 orders
  8. Short-contact 5% cysteamine clinical trial
Dermapedia on YouTube